Cancer Research
Lilly has been involved in cancer research for more than fifty years, working to improve the lives of people living with cancer. Learn more about cancer research at Lilly and how you can make an impact.
Learn MoreThe reason for this study is to see if the study drug LY3295668 erbumine is safe in participants with relapsed/refractory neuroblastoma.
Participants must have relapsed/refractory neuroblastoma and have active disease in at least one site: bone, bone marrow or soft tissue.
Participants must be able to submit an archival sample of tissue
Participants must be able to swallow capsules
Participants must not have had an allogeneic hematopoietic stem cell, bone marrow, or solid organ transplant
Participants must not have untreated tumor that has spread to the brain or spinal cord
Participants must not have a serious active disease other than neuroblastoma
Participants must not have a condition affecting absorption
Participants must not have had prior aurora kinase inhibitor exposure
Participants must not have a known allergy to the study treatment
Participants must not have symptomatic human immunodeficiency virus (HIV) infection or symptomatic activated/reactivated hepatitis A, B, or C
Lilly has been involved in cancer research for more than fifty years, working to improve the lives of people living with cancer. Learn more about cancer research at Lilly and how you can make an impact.
Learn MoreWith the help of research study participants, we are learning about pediatric conditions and potential new approaches to treating disease.
Learn MoreA clinical trial is a scientific study. It helps us learn if a new medicine or treatment works and how it works. Clinical trials can also be called clinical research studies. Learn more about clinical research studies and what to expect when taking part in a clinical trial.